保欣暢通 軟膠囊食品
保欣暢通 軟膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| d-α-TOCOPHEROL (100.18 IU VITAMIN E) | d-α-TOCOPHEROL (100.18 IU VITAMIN E) | Vitamine E |
| d-α-TOCOPHEROL | d-α-TOCOPHEROL | Vitamine E |
| SUNFLOWER OIL | SUNFLOWER OIL | Not identified |
| LECITHIN FROM SOYBEAN | LECITHIN FROM SOYBEAN | Not identified |
| GARLIC OIL MACERATE | GARLIC OIL MACERATE | Not identified |
| HAWTHORN EXTRACT (CRATAEGUS LAEVIGATA, BERRY) | HAWTHORN EXTRACT (CRATAEGUS LAEVIGATA, BERRY) | Not identified |
| COENZYME Q10 | COENZYME Q10 | Ubiquinone |
| MENAQUINONE | MENAQUINONE | Vitamine K |
| VITAMIN K2 | VITAMIN K2 | Vitamine K |
| CALCIUM PHOSPHATE, DIBASIC | CALCIUM PHOSPHATE, DIBASIC | Calcium |
| GELATIN (BOVINE) | GELATIN (BOVINE) | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| WATER | WATER | Not identified |
| PURIFIED WATER | PURIFIED WATER | Not identified |
| ALLURA RED AC | ALLURA RED AC | Not identified |
| IRON OXIDES RED | IRON OXIDES RED | Not identified |
| CARMINE RED | CARMINE RED | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- 1149091466
- Chinese name
- 保欣暢通 軟膠囊食品
- English name
- BAUXINCHUNGTON SOFTGELS
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 京旺生物科技事業有限公司
- Registration date
- 2026-02-25
- Published validity end
- 2031-02-25
Original register data
View published fields and their variants
- Product name
- 保欣暢通 軟膠囊食品
- Active ingredients
- d-α-TOCOPHEROL (100.18 IU VITAMIN E);;d-α-TOCOPHEROL;;SUNFLOWER OIL;;LECITHIN FROM SOYBEAN;;GARLIC OIL MACERATE;;HAWTHORN EXTRACT (CRATAEGUS LAEVIGATA, BERRY);;COENZYME Q10;;MENAQUINONE;;VITAMIN K2;;CALCIUM PHOSPHATE, DIBASIC;;GELATIN (BOVINE);;GLYCEROL;;GLYCEROL;;WATER;;PURIFIED WATER;;ALLURA RED AC;;IRON OXIDES RED;;CARMINE RED;;
- Valid until
- 1200225
- Registration number
- 1149091466
- Licence holder
- 京旺生物科技事業有限公司
- Registration date
- 1150225
- Published reference
- DHC0B490914669
- Published English name
- BAUXINCHUNGTON SOFTGELS
Official source
View the official register, number 1149091466
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- COENZYME Q10
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.